Rasmus S. Pedersen

Increased omeprazole metabolism in carriers of the <i>CYP2C19*17</i> allele; a pharmacokinetic study in healthy volunteers

R. Michael Baldwin, Staffan Ohlsson, Rasmus S. Pedersen et al. · British Journal of Clinical Pharmacology · 2008 · 143 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

The Hypoalgesic Effect of Oxycodone in Human Experimental Pain Models in Relation to the CYP2D6 Oxidation Polymorphism

Stine T. Zwisler, Thomas P. Enggaard, Lene Noehr‐Jensen et al. · Basic & Clinical Pharmacology & Toxicology · 2009 · 108 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +17

Paroxetine, a cytochrome P450 2D6 inhibitor, diminishes the stereoselective -demethylation and reduces the hypoalgesic effect of tramadol

Sune Laugesen, Thomas P. Enggaard, Rasmus S. Pedersen et al. · Clinical Pharmacology & Therapeutics · 2005 · 101 citations

Medicine, Pharmacology, Pharmacotherapy +17

Impact of CYP2C8*3 on paclitaxel clearance: a population pharmacokinetic and pharmacogenomic study in 93 patients with ovarian cancer

Troels K. Bergmann, Charlotte Brasch‐Andersen, Henrik Gréen et al. · The Pharmacogenomics Journal · 2010 · 96 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +13

Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers

Rasmus S. Pedersen, Per Damkier, Kim Brøsen · European Journal of Clinical Pharmacology · 2006 · 95 citations

Medicine, Pharmacokinetics, Pharmacology +14